154 related articles for article (PubMed ID: 27004472)
1. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
[TBL] [Abstract][Full Text] [Related]
2. The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
Prados MC; Alvarez-Sala R; Blasco R; Chivato T; García Satué JL; García Río FJ; Gómez de Terrero FJ; Villamor J
Cancer; 1994 Sep; 74(5):1552-5. PubMed ID: 8062188
[TBL] [Abstract][Full Text] [Related]
3. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
4. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
5. A correlative study of bronchial cytology, bronchoalveolar lavage (BAL) and serum tumor markers in the diagnosis of lung carcinoma.
Nikliński J; Chyczewski L; Chyczewska E; Laudański J; Furman M
Folia Histochem Cytobiol; 1993; 31(4):211-3. PubMed ID: 8138002
[TBL] [Abstract][Full Text] [Related]
6. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
7. Assessment of local cellular immunity in lung cancer by bronchoalveolar lavage.
Lorenz J; Müller-Quernheim J; Castillo-Höfer C; Doboszỳnska A; Ferlinz R
Klin Wochenschr; 1990 Jul; 68(14):728-34. PubMed ID: 1975283
[TBL] [Abstract][Full Text] [Related]
8. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer.
Rodríguez M; Silva J; López-Alfonso A; López-Muñiz MB; Peña C; Domínguez G; García JM; López-Gónzalez A; Méndez M; Provencio M; García V; Bonilla F
Genes Chromosomes Cancer; 2014 Sep; 53(9):713-24. PubMed ID: 24764226
[TBL] [Abstract][Full Text] [Related]
9. Soluble and cell-associated transferrin receptor in lung cancer.
Dowlati A; Loo M; Bury T; Fillet G; Beguin Y
Br J Cancer; 1997; 75(12):1802-6. PubMed ID: 9192985
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients.
Prados C; Alvarez-Sala R; Gómez de Terrero J; Callol L; García Río F; Gómez Carrera L; Gomez de Terreros Caro J; Alvarez-Sala JL; Espinós D; Villamor J
Jpn J Clin Oncol; 2000 May; 30(5):215-20. PubMed ID: 10857498
[TBL] [Abstract][Full Text] [Related]
12. HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.
Murdaca G; Calamaro P; Lantieri F; Pigozzi S; Mastracci L; Grillo F; Magnani O; Ceppa P; Puppo F; Fiocca R
Virchows Arch; 2018 Oct; 473(4):425-433. PubMed ID: 29845360
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
14. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma.
LeFever A; Funahashi A
Chest; 1990 Dec; 98(6):1397-402. PubMed ID: 2173996
[TBL] [Abstract][Full Text] [Related]
15. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
16. The concentrations of five tumor markers in both BAL fractions in lung cancer patients in relation to cigarette smoking.
Pardos MC; Alvarez-Sala R; Terreros Caro FJ; Gómez L; Gómez de Terreros FJ; Villamor J
Tumori; 1999; 85(6):454-7. PubMed ID: 10774565
[TBL] [Abstract][Full Text] [Related]
17. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
18. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
Li QK; Shah P; Li Y; Aiyetan PO; Chen J; Yung R; Molena D; Gabrielson E; Askin F; Chan DW; Zhang H
J Proteome Res; 2013 Aug; 12(8):3689-96. PubMed ID: 23802180
[TBL] [Abstract][Full Text] [Related]
19. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
[TBL] [Abstract][Full Text] [Related]
20. Histocompatibility antigen expression in pulmonary carcinomas as indication of differentiation and of special subtypes.
Dämmrich J; Müller-Hermelink HK; Mattner A; Buchwald J; Ziffer S
Cancer; 1990 May; 65(9):1942-54. PubMed ID: 2164874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
